Does gabapentin affect blood sugar
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Its Impact on Blood Sugar Levels
Introduction to Gabapentin and Blood Sugar
Gabapentin, a medication commonly used for neuropathic pain, has been associated with varying effects on blood sugar levels. This article synthesizes findings from multiple case reports to provide a comprehensive understanding of how gabapentin may influence blood glucose, highlighting both hypoglycemia and hyperglycemia.
Gabapentin-Induced Hypoglycemia
Case Reports of Hypoglycemia
Several case reports have documented instances of hypoglycemia associated with gabapentin use. The Netherlands Pharmacovigilance Centre Lareb reported six cases of hypoglycemia in patients using gabapentin for neuropathic pain, including both diabetic and non-diabetic individuals. The onset of hypoglycemia occurred within days to weeks of starting gabapentin, and symptoms improved upon discontinuation of the drug in most cases . Another case involved a 47-year-old woman who experienced severe hypoglycemia with a blood glucose level of 33 mg/dL after one week of gabapentin use, with no other identifiable causes for her low blood sugar .
Mechanisms of Hypoglycemia
The potential mechanisms by which gabapentin induces hypoglycemia include its interaction with gamma-aminobutyric acid (GABA) receptors, which play a role in insulin secretion. Additionally, gabapentin's binding to specific subunits of voltage-gated calcium channels in the pancreas may also affect insulin release, leading to lower blood glucose levels 13.
Gabapentin-Induced Hyperglycemia
Case Report of Hyperglycemia
In contrast to the cases of hypoglycemia, there is also evidence suggesting that gabapentin can cause hyperglycemia. A case report described a 63-year-old man with type 2 diabetes who experienced an increase in blood glucose levels from 150 to 165 mg/dL after starting gabapentin for pain management. This increase occurred despite no changes in his other medications or lifestyle, and the hyperglycemia was managed with insulin adjustments .
Mechanisms of Hyperglycemia
While the exact mechanism by which gabapentin might cause hyperglycemia is not well understood, it is listed as a possible adverse effect in the drug's labeling. The case report suggests that gabapentin could be considered a potential cause of unexplained hyperglycemia in patients, particularly when no other factors are identified .
Conclusion
Gabapentin has been associated with both hypoglycemia and hyperglycemia in different patient cases. The drug's interaction with GABA receptors and voltage-gated calcium channels may influence insulin secretion, leading to these varying effects on blood sugar levels. Patients, especially those with diabetes, should be closely monitored for changes in blood glucose when starting gabapentin therapy. Further research is needed to fully understand the mechanisms behind these effects and to establish clear guidelines for managing blood sugar levels in patients taking gabapentin.
Sources and full results
Most relevant research papers on this topic